Assurex Health has announced it has secured $30 million in equity financing.
Assurex, headquartered in Mason, Ohio, is a personalized medicine company specializing in helping physicians determine the right medication for individual patients with behavioral health disorders.
Participants in this round of financing included new investors American Financial Group and Cross Creek Advisors, as well as existing investors Cincinnati Children’s Hospital Medical Center, Sequoia Capital, Claremont Creek Ventures, Mayo Clinic, CincyTech, Allos Ventures and Danmar Capital.
Assurex indicated the funding would go toward increased clinical adoption and development of the company’s GeneSight products. GeneSight is a multi-gene psychotropic test.